ArticleOncoTargets and therapy2023

Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report.

Meshaal Alanzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.